Page last updated: 2024-11-13

sts-135

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide: a synthetic cannabinoid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID57404059
CHEBI ID186830
SCHEMBL ID17309664
MeSH IDM000612217

Synonyms (22)

Synonym
sts-135
CHEBI:186830
1354631-26-7
n-(1-adamantyl)-1-(5-luoropentyl)indole-3-carboxamide
1-(5-fluoropentyl)-n-(adamantan-1-yl)-1h-indole-3-carboxamide
BCP0726000064
n-(adamantan-1-yl)-1-(5-fluoropentyl)-1h-indole-3-carboxamide
unii-e6917946xh
e6917946xh ,
n-(adamantane-1-yl)-1-(5-fluoropentyl)-1h-indole-3-carboxamide
1h-indole-3-carboxamide, 1-(5-fluoropentyl)-n-tricycle(3.3.1.1sup(3,7))dec-1-yl-
j3.369.667a ,
5f-apica
n-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1h-indole-3-carboxamide
SCHEMBL17309664
AKOS025402631
sts 135
DTXSID40725427
1-(5-fluoropentyl)-n-tricyclo[3.3.1.13,7]dec-1-yl-1h-indole-3-carboxamide
BCP04543
n-(1-adamantyl)-1-(5-fluoropentyl)indole-3-carboxamide
PD133243
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolecarboxamide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.68 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index80.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]